Vascular endothelial cell function pathways

Vascular endothelial cell function pathways represent the integrated signaling networks that maintain the physiological health and responsiveness of the vascular endothelium [1]. These pathways regulate critical processes such as vascular tone, blood pressure, inflammatory cell trafficking, and the formation of new blood vessels (angiogenesis) [1][2]. Key molecular players within these pathways include endothelial nitric oxide synthase (eNOS), vascular endothelial growth factor (VEGF), and various adhesion molecules like ICAM-1 and VCAM-1 [2][3]. Endothelial dysfunction, characterized by an imbalance in these pathways, is a primary driver of cardiovascular diseases, including atherosclerosis and hypertension, and plays a significant role in tumor progression and diabetic complications [1][4]. Therapeutic strategies often focus on specific nodes within these pathways, such as using VEGF inhibitors to treat cancer or ACE inhibitors and statins to restore nitric oxide bioavailability and improve overall endothelial health [3][5]. Monitoring these pathways in clinical settings often involves measuring biomarkers like flow-mediated dilation (FMD) or circulating levels of von Willebrand factor and soluble adhesion molecules [4][5]. Because these pathways are ubiquitous and involve multiple organ systems, pharmacological modulation requires careful management to avoid systemic side effects like hypertension or impaired wound healing [3][5].

Other names

Endothelial functionEndothelial signaling pathwaysVascular homeostasis pathwaysEndothelial cell signaling

Modulation of nitric oxide bioavailability, inhibition of growth factor signaling (e.g., VEGF), and regulation of cell-surface adhesion molecules to maintain vascular integrity and tone.